IDEAYA Biosciences, Inc. (IDYA)
34.08
-1.26
(-3.57%)
USD |
NASDAQ |
Dec 09, 16:00
34.20
+0.12
(+0.35%)
Pre-Market: 09:25
IDEAYA Biosciences Profit Margin (Quarterly): 57.37% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 39.21% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| GT Biopharma, Inc. | -- |
| Zymeworks, Inc. | -70.99% |
| Belite Bio, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -15.12% |
| Return on Assets | -14.12% |
| Return on Invested Capital | -14.79% |
| Gross Profit Margin (Quarterly) | 99.50% |
| Operating Margin (Quarterly) | 52.18% |
| Return on Net Operating Assets | -528.3% |